Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF NOVEMBER 26, 2020 SAM #6937
SOLICITATION NOTICE

A -- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

Notice Date

11/24/2020 10:44:28 AM
 

Notice Type

Solicitation
 

NAICS

541714 — Research and Development in Biotechnology (except Nanobiotechnology)
 

Contracting Office

ASPR OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE Washington DC 20201 USA
 

ZIP Code

20201
 

Solicitation Number

BARDABAA
 

Response Due

10/31/2021 12:00:00 AM
 

Archive Date

10/31/2021
 

Point of Contact

BARDA-BAA@hhs.gov, BARDA-BAA@hhs.gov
 

E-Mail Address

BARDA-BAA@hhs.gov, BARDA-BAA@hhs.gov
(BARDA-BAA@hhs.gov, BARDA-BAA@hhs.gov)
 

Description

We appreciate your interest in partnering with BARDA.� Due to the COVID-19 response, any white papers or full proposals submissions, other than those that are in support of COVID-19, will be put into a queue.� Once the response to COVID-19 has subsided, we will resume normal review of submissions for other research areas of interest.� BARDA will not be able to meet the timelines highlighted in the Broad Agency Announcement.� Thank you for understanding this unprecedented response and delays that will occur. The latest BARDA Broad Agency Announcement (BAA) is amendment 21�posted on�November 24, 2020. Note: COVID-19 response related Areas of Interest includes: AOI 7.7.1 Diagnostic assay for human coronavirus using existing FDA-cleared platforms AOI 7.7.2 Point-of-care diagnostic assay for detection of SARS-CoV-2 virus AOI 7.7.3 Diagnostic assay for detection of COVID-19 disease (SARS-CoV-2 infection), Including Serology Tests AOI 7.7.4 Diagnostic Assay for SARS-CoV-2 as part of FDA-cleared panel for influenza and other respiratory viruses using FDA-cleared platforms AOI 9.2 COVID-19 Therapeutics AOI 17 Advanced Manufacturing Technologies All contracting related inquiries should be sent to BARDA-BAA@hhs.gov. BARDA revised AOI 12.2 Vaccine Production Platform and white papers and full proposals will be accepted through February 28, 2021. BARDA suspended AOI 10 Respiratory Protective Devices and AOI 8.3 COVID-19 Vaccine.�BARDA will continuously review and expedite COVID-19 response related white papers and full proposals. Offerors should also complete the Submission Data Integration Table. The final white paper submission deadline is extended to October 31, 2021. The final full proposal submission deadline is extended to October 31, 2021�or as specified in the invitation letter.
 

Web Link

SAM.gov Permalink
(https://beta.sam.gov/opp/9527bc4b0ec84afdab6ae461e48e63dc/view)
 

Place of Performance

Address: Washington, DC 20515, USA

Zip Code: 20515

Country: USA
 

Record

SN05859976-F 20201126/201125053758 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |